Explore more publications!
Mauritius Healthcare Daily
Got News to Share?

Mauritius Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mauritius Healthcare Daily.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on March 18, 2026

Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
12 hours ago

Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate

Indeterminate GlobeNewswire
2026 MAP Awards presented to 20 organizations for high performance in revenue cycle
13 hours ago

2026 MAP Awards presented to 20 organizations for high performance in revenue cycle

Indeterminate GlobeNewswire
VitalHub Reports Fourth Quarter 2025 Results
13 hours ago

VitalHub Reports Fourth Quarter 2025 Results

Indeterminate GlobeNewswire
Alvotech Q4 2025 and Full Year 2025 Financial Results
13 hours ago

Alvotech Q4 2025 and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Ever Joint Claims Evaluated: What the Science Says About EverJoint Joint Support Ingredients
14 hours ago

Ever Joint Claims Evaluated: What the Science Says About EverJoint Joint Support Ingredients

Indeterminate GlobeNewswire
Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results
14 hours ago

Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

Indeterminate GlobeNewswire
SnoreStop Throat Spray Claims Evaluated: Effective Anti-Snoring Oral Solution with Clinically Proven Ingredients
14 hours ago

SnoreStop Throat Spray Claims Evaluated: Effective Anti-Snoring Oral Solution with Clinically Proven Ingredients

Indeterminate GlobeNewswire
ADR Ratio Change
15 hours ago

ADR Ratio Change

Indeterminate GlobeNewswire
Extendicare Announces Proposed Changes to Board of Directors
15 hours ago

Extendicare Announces Proposed Changes to Board of Directors

Indeterminate GlobeNewswire
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
15 hours ago

Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026

Indeterminate GlobeNewswire
Big Ed's Meds Under Investigation: Safe FDA-Approved ED Medications for Men
15 hours ago

Big Ed's Meds Under Investigation: Safe FDA-Approved ED Medications for Men

Indeterminate GlobeNewswire
XOMA Royalty Declares Quarterly Preferred Stock Dividends
15 hours ago

XOMA Royalty Declares Quarterly Preferred Stock Dividends

Indeterminate GlobeNewswire
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
16 hours ago

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

Indeterminate GlobeNewswire
Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson’s Disease
16 hours ago

Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson’s Disease

Indeterminate GlobeNewswire
BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
16 hours ago

BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

Indeterminate GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16 hours ago

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
16 hours ago

4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

Indeterminate GlobeNewswire
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
16 hours ago

Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026

Indeterminate GlobeNewswire
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
16 hours ago

ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board

Indeterminate GlobeNewswire
Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System
16 hours ago

Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions